The flip side: Identifying small molecule regulators of nuclear receptors

Chemistry and Biology

Volumn 11, Issue 5, 2004, Pages 639-646

  Schulman, Ira G ^a   Heyman, Richard A ^a  

^a EXELIXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; LIGAND;

ANIMAL; CONFORMATION; DRUG DESIGN; DRUG POTENTIATION; HUMAN; METABOLISM; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR CONFORMATION; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 2642551635     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2003.12.021     Document Type: Review

References (52)

1. Maglich J.M., Sluder A., Guan X., Shi Y., McKee D.D., Carrick K., Kamdar K., Willson T.M., Moore J.T. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2:2001;00029. 1.-00029.7.
2. Howell A., Howell S.J., Evans D.G. New approaches to the endocrine prevention and treatment of breast cancer. Cancer Chemother. Pharmacol. 52(Suppl 1):2003;S39-S44
3. Adcock I.M. Glucocorticoids. new mechanisms and future agents Curr. Allergy Asthma Rep. 3:2003;249-257
4. Willson T.M., Lambert M.H., Kliewer S.A. Peroxisome proliferator- activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 70:2001;341-367
5. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895
6. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain. structure and function Curr. Opin. Cell Biol. 10:1998;384-391
7. Pike A.C., Brzozowski A.M., Hubbard R.E. A structural biologist's view of the oestrogen receptor. J. Steroid Biochem. Mol. Biol. 74:2000;261-268
8. Renaud J.P., Moras D. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57:2000;1748-1769
9. Westin S., Rosenfeld M.G., Glass C.K. Nuclear receptor coactivators. Adv. Pharmacol. 47:2000;89-112
10. Feng W., Ribeiro R.C., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick R.J., Baxter J.D., Kushner P.J., West B.L. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280:1998;1747-1749
11. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141
12. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators. cellular and molecular biology Endocr. Rev. 20:1999;321-344
13. Mak H.Y., Hoare S., Henttu P.M.A., Parker M.G. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol. 19:1999;3895-3903
14. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736
15. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.M., Krones A., Inostroza J., Torchia J., Nolte R.T., Assa-Munt N., et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:1998;3357-3368
16. Shao G., Heyman R.A., Schulman I.G. Three amino acids specify coactivator choice by retinoid X receptors. Mol. Endocrinol. 14:2000;1198-1209
17. Zhou G., Cummings R., Li Y., Mitra S., Wilkinson H.A., Elbrecht A., Hermes J.D., Schaeffer J.M., Smith R.G., Moller D.E. Nuclear receptors have distinct affinities for coactivators. characterization by fluorescence resonance energy transfer Mol. Endocrinol. 12:1998;1594-1604
18. Liu J., Knappenberger K.S., Kack H., Andersson G., Nilsson E., Dartsch C., Scott C.W. A homogeneous in vitro functional assay for estrogen receptors. coactivator recruitment Mol. Endocrinol. 17:2003;346-355
19. Parker G.J., Law T.L., Lenoch F.J., Bolger R.E. Development of high throughput screening assays using fluorescence polarization. nuclear receptor-ligand-binding and kinase/phosphatase assays J. Biomol. Screen. 5:2000;77-88
20. Willson T.M., Moore J.T. Genomics versus orphan nuclear receptors - a half-time report. Mol. Endocrinol. 16:2002;1135-1144
21. Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 345:1990;224-229
22. Levin L.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., et al. 9-Cis retinoic acid sterioisomer binds and activates the nuclear receptor RXRα Nature. 355:1992;359-361
23. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397-406
24. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850
25. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPARγ2. tissue-specific regulator of an adipocyte enhancer Genes Dev. 8:1994;1224-1234
26. 2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812
27. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1995;1033-1045
28. Peet D.J., Turley S.D., Ma W., Janowski B.A., Lobaccaro J.-M.A., Hammer R.E., Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα Cell. 93:1998;693-704
29. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signaling pathway mediated by the nuclear receptor LXRα Nature. 383:1996;728-731
30. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., Chen M., Noh G., Goodman J., Hagger G.N., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA. 99:2002;7604-7609
31. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., Daige C.L., Thomas D., Heyman R.A., Mangelsdorf D.J., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA. 99:2002;11896-11901
32. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., Shan B. Identification of a nuclear receptor for bile acids. Science. 284:1999;1362-1365
33. Wang H., Chen J., Hollister K., Sowers L.C., Forman B.M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3:1999;543-553
34. Kliewer S.A. The nuclear pregnane X receptor regulates xenobiotic detoxification. J. Nutr. 133:2003;2444S-2447S
35. Wei P., Zhang J., Dowhan D.H., Han Y., Moore D.D. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2:2002;117-126
36. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors. shifting endocrinology into reverse Science. 284:1999;757-760
37. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M. Transcriptional repression of atherogenic inflammation. modulation by PPARdelta Science. 302:2003;453-457
38. Kallen J.A., Schlaeppi J.M., Bitsch F., Geisse S., Geiser M., Delhon I., Fournier B. X-ray structure of the hRORalpha LBD at 1.63 A. structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha Structure (Camb). 10:2002;1697-1707
39. Stehlin C., Wurtz J.M., Steinmetz A., Greiner E., Schule R., Moras D., Renaud J.P. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J. 20:2001;5822-5831
40. Wisely G.B., Miller A.B., Davis R.G., Thornquest A.D. Jr., Johnson R., Spitzer T., Sefler A., Shearer B., Moore J.T., Willson T.M., et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Camb). 10:2002;1225-1234
41. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P., Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature. 423:2003;555-560
42. Baker K.D., Shewchuk L.M., Kozlova T., Makishima M., Hassell A., Wisely B., Caravella J.A., Lambert M.H., Reinking J.L., Krause H., et al. The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway. Cell. 113:2003;731-742
43. Solomin L., Johansson C.B., Zetterstrom R.H., Bissonnette R.P., Heyman R.A., Olson L., Lendahl U., Frisen J., Perlmann T. Retinoid-X receptor signaling in the developing spinal cord. Nature. 395:1998;398-402
44. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMS. Science. 295:2002;2465-2468
45. McDonnell D.P., Connor C.E., Wijayaratne A., Chang C.Y., Norris J.D. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 57:2002;295-316
46. Chang C., Norris J.D., Gronemeyer H., Paige L.A., Hamilton P.T., Kenan D.J., Fowlkes D., McDonnell D.P. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries. discovery of peptide antagonists of estrogen receptors alpha and beta Mol. Cell. Biol. 19:1999;8226-8239
47. Rocchi S., Picard F., Vamecq J., Gelman L., Potier N., Zeyer D., Dubuquoy L., Bac P., Champy M.F., Plunket K.D., et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8:2002;737-747
48. Picard F., Gehin M., Annicotte J.-S., Rocchi S., Champy M.F., O'Malley B.W., Chambon P., Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell. 111:2002;931-941
49. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer. 1:2001;34-45
50. Cochran A.G. Protein-protein interfaces. mimics and inhibitors Curr. Opin. Chem. Biol. 5:2001;654-659
51. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 375:1995;377-382
52. Egea P.F., Mitschler A., Rochel N., Ruff M., Chambon P., Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand. 9-cis retinoic acid EMBO J. 19:2000;2592-2601